SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-056036
Filing Date
2023-07-11
Accepted
2023-07-11 08:32:07
Documents
3
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea181589-6k_altamira.htm 6-K 20254
2 FORM OF SECURITIES PURCHASE AGREEMENT ea181589ex10-1_altamira.htm EX-10.1 214506
3 PRESS RELEASE DATED JULY 6, 2023 ea181589ex99-1_altamira.htm EX-99.1 11486
  Complete submission text file 0001213900-23-056036.txt   247596
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 231081254
SIC: 2834 Pharmaceutical Preparations